Literature DB >> 9588894

Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

L G Kindblom1, H E Remotti, F Aldenborg, J M Meis-Kindblom.   

Abstract

The interstitial cells of Cajal (ICC) form a complex cell network within the gastrointestinal tract wall where they function as a pacemaker system. Expression of the kit proto-oncogene is essential for the development of this system. The aim of our study was to examine the hypothesis that gastrointestinal stromal tumors differentiate toward cells with an ICC phenotype. Ultrastructurally, 58 stromal tumors were characterized and found to share many features with ICC. Seventy-eight stromal tumors were immunophenotyped, particularly with regard to the kit receptor. All 78 tumors revealed strong, homogeneous immunoreactivity for the kit receptor as did ICC of adjacent and control gastrointestinal walls. Focal hyperplasia and hypertrophy of kit receptor positive cells were also observed in the gastrointestinal wall adjacent to the tumors. CD34 immunoreactivity observed in interstitial cells surrounding Auerbach's ganglia suggests that a subpopulation of ICC is CD34 positive and may explain why 56 of 78 stromal tumors were CD34 positive. Thirty control tumors, including gastrointestinal leiomyomas and leiomyosarcomas, were all negative for the kit receptor. We conclude that gastrointestinal stromal tumors show striking morphological and immunophenotypic similarities with ICC and that they may originate from stem cells that differentiate toward a pacemaker cell phenotype. We propose that the noncommittal name "gastrointestinal stromal tumor" be replaced by gastrointestinal pacemaker cell tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588894      PMCID: PMC1858579     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Gastrointestinal autonomic nerve (GAN) tumor. Ultrastructural evidence for a newly recognized entity.

Authors:  P Walker; A M Dvorak
Journal:  Arch Pathol Lab Med       Date:  1986-04       Impact factor: 5.534

2.  Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years.

Authors:  H L Evans
Journal:  Cancer       Date:  1985-11-01       Impact factor: 6.860

3.  Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasm.

Authors:  G A Herrera; H Pinto de Moraes; W E Grizzle; S G Han
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

4.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

5.  Gastrointestinal stromal tumors. An immunohistochemical study of cellular differentiation.

Authors:  M Miettinen
Journal:  Am J Clin Pathol       Date:  1988-05       Impact factor: 2.493

Review 6.  Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn't know.

Authors:  H D Appelman
Journal:  Am J Surg Pathol       Date:  1986       Impact factor: 6.394

7.  Gastrointestinal autonomic nerve tumors. 'Plexosarcomas'.

Authors:  G A Herrera; L Cerezo; J E Jones; J Sack; W E Grizzle; W J Pollack; R L Lott
Journal:  Arch Pathol Lab Med       Date:  1989-08       Impact factor: 5.534

8.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.

Authors:  B Chabot; D A Stephenson; V M Chapman; P Besmer; A Bernstein
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

9.  The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene.

Authors:  E N Geissler; M A Ryan; D E Housman
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

10.  Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus.

Authors:  F H Qiu; P Ray; K Brown; P E Barker; S Jhanwar; F H Ruddle; P Besmer
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

View more
  430 in total

1.  Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal.

Authors:  T Tsujimura; C Makiishi-Shimobayashi; J Lundkvist; U Lendahl; K Nakasho; A Sugihara; T Iwasaki; M Mano; N Yamada; K Yamashita; A Toyosaka; N Terada
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Expression of embryonic-form smooth muscle myosin heavy chain in a gastrointestinal stromal tumor of the greater omentum.

Authors:  K Tajima; S Fuyama; Y Inaba; M Kera; T Katagiri; T Kato
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

3.  Gastrointestinal pacemaker cell tumour.

Authors:  B Eyden
Journal:  Virchows Arch       Date:  2001-06       Impact factor: 4.064

4.  A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad.

Authors:  Ricardo Celestino; Jorge Lima; Alexandra Faustino; Valdemar Máximo; António Gouveia; João Vinagre; Paula Soares; José Manuel Lopes
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

5.  Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas.

Authors:  Toshiyuki Nakayama; Ayumi Yoshizaki; Shinji Naito; Chun-Yang Wen; Gabit Alipov; Yuichi Yakata; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

6.  Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.

Authors:  Borislav Belev; Iva Brčić; Juraj Prejac; Zrna Antunac Golubić; Damir Vrbanec; Jadranka Božikov; Ivan Alerić; Marko Boban; Jasminka Jakić Razumović
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  A single-institution experience with eight CD117-positive primary extragastrointestinal stromal tumors: critical appraisal and a comparison with their gastrointestinal counterparts.

Authors:  Brian K P Goh; Pierce K H Chow; Sittampalam M Kesavan; Wai-Ming Yap; Yaw-Fui A Chung; Wai-Keong Wong
Journal:  J Gastrointest Surg       Date:  2009-02-24       Impact factor: 3.452

8.  Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.

Authors:  Haluk R Unalp; Hayrullah Derici; Erdinc Kamer; Ali D Bozdag; Ercument Tarcan; Mehmet A Onal
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

9.  Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth.

Authors:  Badreddin Edris; Stephen B Willingham; Kipp Weiskopf; Anne K Volkmer; Jens-Peter Volkmer; Thomas Mühlenberg; Kelli D Montgomery; Humberto Contreras-Trujillo; Agnieszka Czechowicz; Jonathan A Fletcher; Robert B West; Irving L Weissman; Matt van de Rijn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

10.  Analysis of CD117-negative gastrointestinal stromal tumors.

Authors:  Chin-Yuan Tzen; Bey-Liing Mau
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.